High expression of the HSP40 family member DNAJC12 has been found to correlate with colorectal tumor progression and invasion and with a poor response to neoadjuvant concurrent chemoradiotherapy [95]. This evidence concerns the gene DNAJB1 and colorectal neoplasm.